SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-13-005111
Filing Date
2013-04-30
Accepted
2013-04-30 06:05:42
Documents
12
Period of Report
2013-06-26
Effectiveness Date
2013-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2214568zdef14a.htm DEF 14A 787828
2 G202915.JPG g202915.jpg GRAPHIC 17152
3 G1012795.JPG g1012795.jpg GRAPHIC 6628
4 G1010901.JPG g1010901.jpg GRAPHIC 65844
5 G194405.JPG g194405.jpg GRAPHIC 39158
6 G427512.JPG g427512.jpg GRAPHIC 33500
7 G384059.JPG g384059.jpg GRAPHIC 53049
8 G367680.JPG g367680.jpg GRAPHIC 71677
9 G569981.JPG g569981.jpg GRAPHIC 34478
10 G406603.JPG g406603.jpg GRAPHIC 211097
11 G15892BGI001.GIF g15892bgi001.gif GRAPHIC 56579
12 G15892BGI002.GIF g15892bgi002.gif GRAPHIC 54331
  Complete submission text file 0001047469-13-005111.txt   1677128
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26301 | Film No.: 13794195
SIC: 2834 Pharmaceutical Preparations